Literature DB >> 29387774

Dermoscopy of eccrine angiomatous hamartoma: The popcorn pattern.

Sandra Cecilia García-García1, Marcela Saeb-Lima1, Alejandra Villarreal-Martínez1, Osvaldo Tomás Vázquez-Martínez1, Yuri Igor López-Carrera1, Jorge Ocampo-Candiani1, Minerva Gómez-Flores1.   

Abstract

Entities:  

Keywords:  dermoscopy; eccrine angiomatous hamartoma; popcorn pattern

Year:  2018        PMID: 29387774      PMCID: PMC5789522          DOI: 10.1016/j.jdcr.2017.08.014

Source DB:  PubMed          Journal:  JAAD Case Rep        ISSN: 2352-5126


× No keyword cloud information.

Clinical presentation

A 21-year-old woman presented with a congenital red-yellow, velvety plaque on the right side of the neck (Fig 1). She complained of mild pruritus and excessive sweating on that area.
Fig 1

Clinical examination found a red-yellowish, velvety plaque with verrucous surface on the right side of the neck.

Clinical examination found a red-yellowish, velvety plaque with verrucous surface on the right side of the neck.

Dermoscopic appearance

Dermoscopic examination found multiple yellow, confluent nodules in a popcorn shape, over a background of erythema and linear and arborizing blood vessels (Fig 2).
Fig 2

Dermoscopy shows a popcorn pattern of linear yellowish nodules over a background of erythema and linear and arborizing blood vessels.

Dermoscopy shows a popcorn pattern of linear yellowish nodules over a background of erythema and linear and arborizing blood vessels.

Histologic diagnosis

Histopathology found the hamartomatous presence of eccrine gland lobules, accompanied by dilated vascular lumina (Fig 3). A diagnosis of eccrine angiomatous hamartoma (EAH) was made, and treatment with 595-nm pulsed-dye laser was started.
Fig 3

The sections show in a low-power view the hamartomatous presence of 5 to 6 lobules of eccrine glands that are accompanied by some dilated vascular lumina. (Original magnifications: A, ×4; B, ×10; C, ×20.)

EAH is a rare benign malformation characterized by the proliferation of eccrine sweat glands and dilated capillaries. It has no gender predilection and presents at birth or early childhood as a red, violaceous, brown, yellow, or skin-colored nodule or plaque. Associated signs and symptoms include mild pain, hypertrichosis, and sweating. Etiology is unclear, although a defective interaction between the epithelium and mesenchyme resulting in abnormal proliferation of adnexal and vascular structures has been suggested.1, 2 Histopathology results show a well-demarcated lesion in the middle or reticular dermis, with proliferation of normal or enlarged eccrine sweat glands and vascular structures. Treatment options include surgical excision, botulinum toxin for hyperhidrosis, pulsed-dye and neodymium-doped yttrium aluminium garnet lasers. EAH is a heterogeneous entity; however, most of the published cases report similar clinical and histopathologic findings. To the best of our knowledge, this case represents the first dermoscopic description of EAH, and we consider that this pattern may be useful for its diagnosis. However, this is an isolated case, and more cases should be reported to assess the specificity of this pattern. The sections show in a low-power view the hamartomatous presence of 5 to 6 lobules of eccrine glands that are accompanied by some dilated vascular lumina. (Original magnifications: A, ×4; B, ×10; C, ×20.)
  2 in total

1.  Successful treatment of eccrine angiomatous hamartoma with botulinum toxin.

Authors:  Didac Barco; Eulàlia Baselga; Marta Alegre; Romà Curell; Agustín Alomar
Journal:  Arch Dermatol       Date:  2009-03

2.  Eccrine Angiomatous Hamartoma: A Clinicopathological Study of 26 Cases.

Authors:  Tutyana Sanusi; Yanqiu Li; Lan Sun; Chunsen Wang; Youwen Zhou; Changzheng Huang
Journal:  Dermatology       Date:  2015-04-14       Impact factor: 5.366

  2 in total
  1 in total

1.  Dermoscopy of eccrine angiomatous hamartoma: The spitzoid pattern.

Authors:  Awatef Kelati; Christine Chiaverini; Damien Giacchero; Marius Ilie; Jean-Philippe Lacour; Philippe Bahadoran
Journal:  JAAD Case Rep       Date:  2018-09-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.